Evaluate Research provides institutional quality equity research on public midcap companies on a global basis. Our 40-page plus Initiation Reports evaluate in great details all aspects of publicly-traded companies: growth opportunities, catalysts, business description, competitive positioning, SWOT analysis, risks, etc. In addition, we determine specific price targets for all covered companies based on detailed 5-year complete forecasts of financial statements including IS, BS, CF, ratios, etc. Our price targets are supported by long-term DCF models. All of our research reports are broadly disseminated globally on the leading investment information platforms including: Bloomberg, S&P Capital IQ, Thomson Reuters, FactSet, Morningstar as well as on our own website.
Company Details
- Employees
- 2
- Address
- 30/ F, Singapore Land Tower, 50 Raffles Place,singapore
- Industry
- Financial Services
- NAICS
-
Finance and InsuranceMonetary Authorities-Central Bank
- Website
- evaluateresearch.com
- Keywords
- Research on undervalued, underfollowed companies, High quality, detailed and objective analysis, Complete 5 year forecast models.
- HQ
- Singapore
Evaluate Research Ltd. Questions
Evaluate Research Ltd.'s website is evaluateresearch.com
Evaluate Research Ltd.'s LinkedIn profile is https://sg.linkedin.com/company/evaluate-research-ltd-
Evaluate Research Ltd. has
2 employees.
View email and phone details for 2
employees at Evaluate Research Ltd..
Evaluate Research Ltd.'s industry is
Financial Services
Evaluate Research Ltd.'s top competitors are
Evaluate Consulting Services,
Pan-Asian Clinical Research Association (Pacra),
Hexatic,
Batlivala & Karani Group,
Hdfc Securities,
Eastbridge Capital,
Cru Global Network,
Azura Medica,
Femwealth,
E-Volve Corporate Technology.
Evaluate Research Ltd.'s categories are Financial Services
